US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Emmaus Life Sciences, Inc.

0.0150

-0.0020-11.76%

Volume:30.00K

Turnover:450.00

Market Cap:957.98K

PE:-0.17

High:0.0150

Open:0.0150

Low:0.0150

Close:0.0170

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Emmaus Life Sciences, Inc.

Exchange:

OTCQB

Establishment Date:

2000

Employees:

35

Office Location:

21250 Hawthorne Boulevard,Suite 800,Torrance,California,United States

Website:

http://www.MYndAnalytics.com

Zip Code:

90503

Phone:

Fax:

310 214 0075

Introduction:

Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. The company's lead candidate is Endari, an L-glutamine oral powder to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older. It has a collaboration agreement with Kainos Medicine, Inc. for the preclinical development of Kainos' patented IRAK4 inhibitor (KM10544) as an anti-cancer drug. The company was formerly known as Emmaus Holdings, Inc. and changed its name to Emmaus Life Sciences, Inc. in September 2011. The company was founded in 2000 and is headquartered in Torrance, California.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/EMMA/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EMMA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EMMA\",,,,,undefined,":{"symbol":"EMMA","market":"US","secType":"STK","nameCN":"Emmaus Life Sciences, Inc.","latestPrice":0.015,"timestamp":1750449600000,"preClose":0.017,"halted":0,"volume":30000,"delay":15,"floatShares":35988185,"shares":63865571,"eps":-0.089832,"marketStatus":"Market Closed","change":-0.002,"latestTime":"06-20 16:00:00 EDT Delay","open":0.015,"high":0.015,"low":0.015,"amount":450,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.089832,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750665600000},"marketStatusCode":7,"adr":0,"exchange":"OTCQB","adjPreClose":0.017,"volumeRatio":1.9154886191377778},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EMMA\",,,,,undefined,":{"symbol":"EMMA","floatShares":35988185,"roa":"-0.32%","roe":"-13.36%","lyrEps":-0.070294,"volumeRatio":1.9154886191377778,"shares":63865571,"dividePrice":0,"high":0.015,"amplitude":0,"preClose":0.017,"low":0.015,"week52Low":0.0001,"pbRate":"-0.02","psRate":"0.06","week52High":0.10115,"institutionHeld":0,"latestPrice":0.015,"eps":-0.089832,"divideRate":0,"volume":30000,"delay":15,"ttmEps":-0.089832,"open":0.015,"prevYearClose":0.0085,"prevWeekClose":0.017,"prevMonthClose":0.0199,"prevQuarterClose":0.0171,"fiveDayClose":0.017,"twentyDayClose":0.014,"sixtyDayClose":0.0189},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":39585025,"yearFounded":2000,"employeeNum":35,"address":"21250 Hawthorne Boulevard,Suite 800,Torrance,California,United States","zipCode":"90503","officePhone":"310 214 0065","officeFax":"310 214 0075"},"stockCompanyDetail":{"websiteUrl":"http://www.MYndAnalytics.com","stockEarnings":[{"period":"1week","weight":-0.1429},{"period":"1month","weight":-0.3498},{"period":"3month","weight":-0.7651},{"period":"6month","weight":-0.72},{"period":"1year","weight":-0.7558},{"period":"ytd","weight":-0.5219}],"description":"Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. The company's lead candidate is Endari, an L-glutamine oral powder to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older. It has a collaboration agreement with Kainos Medicine, Inc. for the preclinical development of Kainos' patented IRAK4 inhibitor (KM10544) as an anti-cancer drug. The company was formerly known as Emmaus Holdings, Inc. and changed its name to Emmaus Life Sciences, Inc. in September 2011. The company was founded in 2000 and is headquartered in Torrance, California.","exchange":"OTCQB","name":"Emmaus Life Sciences, Inc.","nameEN":"Emmaus Life Sciences, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"EMMA\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EMMA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-19","symbol":"EMMA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731992400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-11-14","symbol":"EMMA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1668402000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-08-15","symbol":"EMMA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1660536000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2019-11-12","symbol":"EMMA","fiscalQuarterEnding":null,"expectedEps":-1.32,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1573534800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2019-08-12","symbol":"EMMA","fiscalQuarterEnding":"2019/06","expectedEps":-1.56,"name":null,"time":"","type":"earning","dateTimestamp":1565582400000,"reportTimeType":"","actualEps":-1.2}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EMMA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EMMA\",market:\"US\",delay:false,,,undefined,":{}}}